BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 22091929)

  • 1. The introduction of a choice to learn pre-symptomatic DNA test results for BRCA or Lynch syndrome either face-to-face or by letter.
    Voorwinden JS; Jaspers JP; ter Beest JG; Kievit Y; Sijmons RH; Oosterwijk JC
    Clin Genet; 2012 May; 81(5):421-9. PubMed ID: 22091929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Factors for Distress After Genetic Testing for Hereditary Cancer.
    Voorwinden JS; Jaspers JP
    J Genet Couns; 2016 Jun; 25(3):495-503. PubMed ID: 26475052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; van Gool AR; Klijn JG; Tibben A
    Clin Genet; 2007 Jan; 71(1):35-42. PubMed ID: 17204044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic counseling does not fulfill the counselees' need for certainty in hereditary breast/ovarian cancer families: an explorative assessment.
    Vos J; Menko FH; Oosterwijk JC; van Asperen CJ; Stiggelbout AM; Tibben A
    Psychooncology; 2013 May; 22(5):1167-76. PubMed ID: 22777929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
    Patient Educ Couns; 2007 Jan; 65(1):58-68. PubMed ID: 16872788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient satisfaction and cancer-related distress among unselected Jewish women undergoing genetic testing for BRCA1 and BRCA2.
    Metcalfe KA; Poll A; Llacuachaqui M; Nanda S; Tulman A; Mian N; Sun P; Narod SA
    Clin Genet; 2010 Nov; 78(5):411-7. PubMed ID: 20653694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Satisfaction and Low Distress in Breast Cancer Patients One Year after BRCA-Mutation Testing without Prior Face-to-Face Genetic Counseling.
    Sie AS; Spruijt L; van Zelst-Stams WA; Mensenkamp AR; Ligtenberg MJ; Brunner HG; Prins JB; Hoogerbrugge N
    J Genet Couns; 2016 Jun; 25(3):504-14. PubMed ID: 26531312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Communicating cancer risk within an African context: experiences, disclosure patterns and uptake rates following genetic testing for Lynch syndrome.
    Bruwer Z; Futter M; Ramesar R
    Patient Educ Couns; 2013 Jul; 92(1):53-60. PubMed ID: 23453851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. More breast cancer patients prefer BRCA-mutation testing without prior face-to-face genetic counseling.
    Sie AS; van Zelst-Stams WA; Spruijt L; Mensenkamp AR; Ligtenberg MJ; Brunner HG; Prins JB; Hoogerbrugge N
    Fam Cancer; 2014 Jun; 13(2):143-51. PubMed ID: 24068317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors for hereditary cancer distress six months after BRCA1/2 or HNPCC genetic susceptibility testing.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
    Eur J Cancer; 2007 Jan; 43(1):71-7. PubMed ID: 17045473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey.
    Di Prospero LS; Seminsky M; Honeyford J; Doan B; Franssen E; Meschino W; Chart P; Warner E
    CMAJ; 2001 Apr; 164(7):1005-9. PubMed ID: 11314429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intention to learn results of genetic testing for hereditary colon cancer.
    Vernon SW; Gritz ER; Peterson SK; Perz CA; Marani S; Amos CI; Baile WF
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):353-60. PubMed ID: 10207640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the short-term impact of DNA-testing in breast cancer patients: the counselees' perception matters, but the actual BRCA1/2 result does not.
    Vos J; Oosterwijk JC; Gomez-Garcia E; Menko FH; Collee MJ; van Asperen CJ; Jansen AM; Stiggelbout AM; Tibben A
    Patient Educ Couns; 2012 Feb; 86(2):239-51. PubMed ID: 21684708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct contact in inviting high-risk members of hereditary colon cancer families to genetic counselling and DNA testing.
    Aktan-Collan K; Haukkala A; Pylvänäinen K; Järvinen HJ; Aaltonen LA; Peltomäki P; Rantanen E; Kääriäinen H; Mecklin JP
    J Med Genet; 2007 Nov; 44(11):732-8. PubMed ID: 17630403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No evidence of false reassurance among women with an inconclusive BRCA1/2 genetic test result.
    Dorval M; Gauthier G; Maunsell E; Dugas MJ; Rouleau I; Chiquette J; Plante M; Laframboise R; Gaudet M; Bridge PJ; Simard J
    Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2862-7. PubMed ID: 16365001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive Genetic Testing and Alternatives to Face to Face Results Disclosure: A Retrospective Review of Patients Preference for Alternative Modes of BRCA 1 and 2 Results Disclosure in the Republic of Ireland.
    O'Shea R; Meany M; Carroll C; Cody N; Healy D; Green A; Lynch SA
    J Genet Couns; 2016 Jun; 25(3):422-31. PubMed ID: 26407988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of counselee and counselor satisfaction in reproductive genetic counseling.
    Aalfs CM; Oort FJ; de Haes JC; Leschot NJ; Smets EM
    Clin Genet; 2007 Aug; 72(2):74-82. PubMed ID: 17661810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics affect the impact of an uninformative DNA test result: the course of worry and distress experienced by women who apply for genetic testing for breast cancer.
    van Dijk S; Timmermans DR; Meijers-Heijboer H; Tibben A; van Asperen CJ; Otten W
    J Clin Oncol; 2006 Aug; 24(22):3672-7. PubMed ID: 16877736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic testing offered directly after the diagnosis of colorectal cancer: a pilot study on the reactions of patients.
    Landsbergen KM; Prins JB; Brunner HG; Hoogerbrugge N
    Genet Couns; 2009; 20(4):317-25. PubMed ID: 20162866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perceiving cancer-risks and heredity-likelihood in genetic-counseling: how counselees recall and interpret BRCA 1/2-test results.
    Vos J; Oosterwijk JC; Gómez-García E; Menko FH; Jansen AM; Stoel RD; van Asperen CJ; Tibben A; Stiggelbout AM
    Clin Genet; 2011 Mar; 79(3):207-18. PubMed ID: 21114486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.